Protocols for Preparation and Mass Spectrometry Analysis of Clinical Urine Samples to Identify Candidate Biomarkers of Schistosoma-Associated Bladder Cancer
- 3 March 2021
- book chapter
- protocol
- Published by Springer Science and Business Media LLC
- Vol. 2292, 143-150
- https://doi.org/10.1007/978-1-0716-1354-2_13
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Quantitative label-free proteomic analysis of human urine to identify novel candidate protein biomarkers for schistosomiasisPLoS Neglected Tropical Diseases, 2017
- Biomarker discovery in mass spectrometry‐based urinary proteomicsProteomics – Clinical Applications, 2015
- Clinical implications of recent findings in schistosome proteomicsExpert Review of Proteomics, 2015
- Impact of human schistosomiasis in sub-Saharan AfricaThe Brazilian Journal of Infectious Diseases, 2015
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric CancersClinical Chemistry, 2010
- Preparation of Urine Samples for Proteomic AnalysisMethods in molecular biology (Clifton, N.J.), 2008
- Advances in Urinary Proteome Analysis and Biomarker DiscoveryJournal of the American Society of Nephrology, 2007
- Stop and Go Extraction Tips for Matrix-Assisted Laser Desorption/Ionization, Nanoelectrospray, and LC/MS Sample Pretreatment in ProteomicsAnalytical Chemistry, 2002